Feasibility Study of a Transition Pathway at Discharge From Full Hospitalization in Oncology

NCT07256444 | Recruiting

• 1 other identifier: NIMAO/2023-2/AB01
• Study Type: observational
• Target: 50
• Locations: 1 country
• Sites: 1

Brief Summary

Patient reported outcomes (PRO) measure the health status directly reported by the patients, without external interpretation, generally collected using self-questionnaires, including online tools (ePRO). This approach is useful in early detection of signs of relapse, with reduced anxiety, improved quality of life and survival, and reduced readmissions to emergency departments in patients with advanced cancer. In the current context where hospitalization is increasingly short, the transition from hospital to home is a critical moment that poses a significant safety challenge Patient follow-up strategies help patients return home, particularly in surgery, with telephone calls from a nurse the day after or several days after discharge. In oncology, telephone calls from the pharmacist 3 days after discharge from hospital helped to identify undesirable effects of treatments. In general medicine, these calls have led to improved patient satisfaction, reduced use of emergency departments and the resolution of drug-related problems, but are costly. The introduction of post-hospitalization ePRO monitoring in oncology could ensure effective follow-up while keeping costs under control. A coordinating nurse could manage this process and play a crucial role in accompanying patients when they return home. The study authors aimed to evaluate the feasibility of a transitional nurse consultation and ePRO follow-up on discharge from full hospitalization in oncology in this population of frail and elderly patients.

Conditions

Cancer

Outcome Measures

Primary Outcomes (3)

• Compliance with ePRO monitoring

  Percentage of patients who responded to all questionnaires

  Day 2

• Compliance with the telephone call at day 7

  Percentage of patients successfully contacted at day 7

  Day 7

• Patient satisfaction with the care pathway

  Question: "Are you satisfied with your care pathway?" (Yes/no)

  Day 15

Secondary Outcomes (7)

• Quality of the transition pathway to home

  Day 15

• Quality of life as reported by the patient

  Day 0

• Quality of life as reported by the patient

  Day 7

• Quality of life as reported by the patient

  Day 15

• Quality of life as reported by the patient

  Day 30

Interventions

OncoCare transition program OTHER

Interview with the coordinating nurse who reviews the patient's prescriptions and appointments, installs the electronic patient-reported outcome (ePRO) application on the patient's smartphone and explains collection of any symptoms. ePRO symptom monitoring by the patient on D2, D7 and D15 after discharge. The coordinating nurse phones the patient on D7 to review the symptoms reported, assess compliance with treatment and provide support. In the event of grade ≥ 2 symptoms, the nurse contacts the patient for further information and informs the referring oncologist, who decides on the course of treatment.

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Consecutive patients treated as inpatients in the Medical Oncology Department of Nîmes University Hospital and scheduled to be discharged and returned home.

You may qualify if:

• The patient must have given their free and informed consent and signed the consent form
• The patient must be a member or beneficiary of a health insurance plan
• Adult patient hospitalized in an oncology unit for at least 48 hours.
• Patient capable of using a connected device, in possession of a smartphone or tablet, and with an internet connection at home.
• Patient discharged from hospital to go home.

You may not qualify if:

• The subject refuses to sign the consent
• It is impossible to give the subject informed information
• The patient is under safeguard of justice or state guardianship
• Patient considered to be at the end of life.
• Patient unable to read and understand French
• Patient discharged from hospitalization to a home care facility
• Patient having been hospitalized in a full-time inpatient setting for a scheduled procedure (chemotherapy or interventional procedure)
• Pregnant, parturient, or breastfeeding

Sponsors & Collaborators

• Centre Hospitalier Universitaire de Nīmes: lead

Study Sites (1)

Centre Hospitalier de Nimes

Nîmes, 30000, France

RECRUITING

MeSH Terms

Conditions

Neoplasms

Study Officials

• Astrid Basset

  CHU de Nimes

  PRINCIPAL INVESTIGATOR

Central Study Contacts

Astrid Basset

CONTACT

06.24.89.63.27; astrid.basset@chu-nimes.fr

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: November 20, 2025
• First Posted: December 1, 2025
• Study Start: March 1, 2026
• Primary Completion (Estimated): December 1, 2028
• Study Completion (Estimated): December 1, 2028
• Last Updated: January 28, 2026

Record last verified: 2026-01

Locations

FR (1)